EMPER: Creation and Evaluation of a Mobile Intervention Team in Perinatal Psychiatry (0-3 Years) in Meurthe-et-Moselle Sud

Sponsor
Centre Psychothérapique de Nancy (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05636878
Collaborator
Centre Hospitalier Régional et Universitaire de Nancy (Other)
4,260
2
58

Study Details

Study Description

Brief Summary

The research system is a Mobile Perinatal Psychiatry Team (EMPPer), for children aged 0 to 3 and their parents. it facilitates access to psychiatric care by going to families who need it and who are in difficulty to ensure this process.

This device, already deployed in a dozen French cities for several years, convinced the teams of its interest, without demonstrating its effectiveness by evaluation conducted according to research standards. The deployment of a Mobile Perinatal Psychiatry Team in a region not yet equipped (Meurthe-et-Moselle Sud) would therefore offer the opportunity to assess its effectiveness,

The main objective of the research is to evaluate the effect of the EMPPer on the prevalence of abnormalities in the psychomotor development of children at the age of 2 years, in comparison with similar territories that do not benefit from it, and in comparison with the period preceding the establishment of the EMPPer in the targeted territory.

Condition or Disease Intervention/Treatment Phase
  • Other: Mobile Intervention Team in Perinatal Psychiatry (EMPPer)
N/A

Detailed Description

Context:

The inflation of psycho-social vulnerability and precariousness situations, of parents or isolated mothers with their young child, who do not have easy access to perinatal psychiatry care structures, incites us to develop a modality of home interventions. This is part of a therapeutic perspective of the parenting process and parent-child interactions and a preventive perspective of the child's development. This system is a Mobile Perinatal Psychiatry Team and is also designed for professionals working in early childhood (such as the homes that take in parents). They are in demand for direct interventions with patients, but also indirect interventions, for assistance in the detection of early disorders in children and for referral to psychiatric care.

The main objective of the research is to evaluate the effect of the EMPPer on the prevalence of abnormalities in the psychomotor development of children at the age of 2 years , in comparison with similar territories that do not benefit from it, and in comparison with the period before the EMPPer was implemented in the targeted territory.

The secondary objectives are:
  • to evaluate the long-term effect of the EMPPer on the prevalence of child language delay at age 4, compared with similar territories without the EMPPer and compared with the period before the EMPPer was implemented in the target territory

  • to evaluate the EMPPer implementation process, in terms of context, interventions implemented, implementation, and impact mechanisms

  • to evaluate the medico-economic impact at 2 years of the implementation of the EMPPer.

Methodology:

EMPER is a quasi-experimental study combining a before-and-after EMPPer implementation design with a here-and-now design. A concomitant process evaluation will also be conducted to assess the actual implementation of the intervention, the impact mechanisms of the intervention on the judgment criteria, and to understand precisely the context of implementation in order to better identify the transferability and sustainability of the intervention.

the study will include all the children of the EMPPer sector as well as those of the Reims and Strasbourg hospital sectors. Data from their 24th month and 3-4 years examinations will be collected .

Process evaluation will be based on mixed methods.It will be based on standardized data collection using an observation book and validated measurement instruments such as the satisfaction and therapeutic alliance questionnaire. It will include all users and professionals involved in the implementation of the EMPPer and willing to participate.

The qualitative approach will make it possible, through field observations and semi-structured interviews with professionals and volunteer users, to specify certain elements relating to the intervention itself, such as the organizations within the EMPPer, but also its implementation (possible adaptations of the intervention) or its impact mechanisms.

Expected results are that the deployment of an EMPPer will allow:
  • To promote early detection of interaction disorders in order to limit theirs consequences on somatic, cognitive and psychomotor development

  • To promote early detection of neurodevelopmental disorders

  • To promote early intervention, in connection with early childhood partners

  • To facilitate the care pathway of the young patient and his family by allowing easier access to care.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
4260 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
For the primary objective, i.e., analysis of the effect of the intervention at age 2 (and the first SO, i.e., analysis of the effect of the intervention at age 4), a difference-in-differences analysis will be performed. That is, the difference in the prevalence of abnormal psychomotor development at age 2 (and at age 4) before and after the implementation of the EMPPer in the target territory will be compared to the difference in the prevalence of abnormal psychomotor development at age 2 (and at age 4) between the periods corresponding to the implementation of the EMPPer in the territories that did not benefit from it, using a mixed linear regression model with psychomotor developmental abnormalities as the variable to be explained, year (pre vs. post intervention) and region (with vs. without intervention) as explanatory variables, and which will include the year*region interaction. The assumption of equivalence of temporal developmental trends here and elsewhere will be testedFor the primary objective, i.e., analysis of the effect of the intervention at age 2 (and the first SO, i.e., analysis of the effect of the intervention at age 4), a difference-in-differences analysis will be performed. That is, the difference in the prevalence of abnormal psychomotor development at age 2 (and at age 4) before and after the implementation of the EMPPer in the target territory will be compared to the difference in the prevalence of abnormal psychomotor development at age 2 (and at age 4) between the periods corresponding to the implementation of the EMPPer in the territories that did not benefit from it, using a mixed linear regression model with psychomotor developmental abnormalities as the variable to be explained, year (pre vs. post intervention) and region (with vs. without intervention) as explanatory variables, and which will include the year*region interaction. The assumption of equivalence of temporal developmental trends here and elsewhere will be tested
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Creation and Evaluation of a Mobile Intervention Team in Perinatal Psychiatry (0-3 Years) in Meurthe-et-Moselle Sud
Anticipated Study Start Date :
Jan 30, 2023
Anticipated Primary Completion Date :
Dec 1, 2027
Anticipated Study Completion Date :
Dec 1, 2027

Arms and Interventions

Arm Intervention/Treatment
Experimental: With EMPPer

All children (0 to 3 years old) in the areas Meurthe-et-Moselle South will benefit from the intervention of the Mobile Perinatal Psychiatry Team (EMPPer)

Other: Mobile Intervention Team in Perinatal Psychiatry (EMPPer)
The Mobile Intervention Team in Perinatal Psychiatry consists in going towards the most excluded patients, changing the organization of care compared to the current practice and facilitating access to care for the most vulnerable populations

No Intervention: without EMPPer

All children (0 to 3 years) from Strasbourg and Reims will not benefit from the Mobile Intervention Team in Perinatal Psychiatry

Outcome Measures

Primary Outcome Measures

  1. Number of participants with anomaly of the child's psychomotor development at age 2 years [up to 24 months]

    It defined by the fact of having at least one box ticked "no" in the psychomotor development section of the medical part of the third health certificate , carried out after a systematic examination at the age of 24 months of the child

Secondary Outcome Measures

  1. Number of Children with Language Delay at age 4 [up to 4 years]

    It evaluated during a health examination systematically carried out at the age of 4 years for the child attending school

  2. Therapeutic alliance score [up to 4 years]

    Therapeutic alliance score (parents of the child) on the Working Alliance Inventory questionnaire (Bottemine, 2017; Horvath 1989)

  3. User satisfaction score [up to 4 years]

    using the questionnaire offered to parents of children in care by the Nancy Psychotherapy Center as part of its quality approach

  4. the cost of care for children with a psychomotor development problem [2 years]

    it makes it possible to carry out a medico-economic analysis, and to estimate the difference in costs between the two strategies of care (with and without EMPPer)

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Day to 3 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Children benefiting from EMPPer intervention

  • Children affiliated or entitled to a social security system

  • Children for whom the holder of parental authority has received informed information about the study and has co-signed, with the investigator, a consent to participate in the study

Exclusion Criteria:
  • Children whose parents are visiting the region ( vacations, family visits ...)

  • Children for whom the 2 holders of parental authority do not speak french

  • Children for whom both parents do not know how to read

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Centre Psychothérapique de Nancy
  • Centre Hospitalier Régional et Universitaire de Nancy

Investigators

  • Principal Investigator: Fabienne LIGIER, Pr., Centre Psychothérapique de Nancy

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Centre Psychothérapique de Nancy
ClinicalTrials.gov Identifier:
NCT05636878
Other Study ID Numbers:
  • RIPH 2021-06
  • 2021-A02678-33
First Posted:
Dec 5, 2022
Last Update Posted:
Dec 21, 2022
Last Verified:
Dec 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre Psychothérapique de Nancy
Additional relevant MeSH terms:

Study Results

No Results Posted as of Dec 21, 2022